Your browser doesn't support javascript.
loading
Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment.
Luo, Han; Xia, Xuyang; Huang, Li-Bin; An, Hyunsu; Cao, Minyuan; Kim, Gyeong Dae; Chen, Hai-Ning; Zhang, Wei-Han; Shu, Yang; Kong, Xiangyu; Ren, Zhixiang; Li, Pei-Heng; Liu, Yang; Tang, Huairong; Sun, Ronghao; Li, Chao; Bai, Bing; Jia, Weiguo; Liu, Yi; Zhang, Wei; Yang, Li; Peng, Yong; Dai, Lunzhi; Hu, Hongbo; Jiang, Yong; Hu, Yiguo; Zhu, Jingqiang; Jiang, Hong; Li, Zhihui; Caulin, Carlos; Park, Jihwan; Xu, Heng.
Afiliação
  • Luo H; Division of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. luohan-hx@scu.edu.cn.
  • Xia X; Laboratory of thyroid and parathyroid disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China. luohan-hx@scu.edu.cn.
  • Huang LB; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. luohan-hx@scu.edu.cn.
  • An H; Division of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. luohan-hx@scu.edu.cn.
  • Cao M; Division of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Kim GD; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Chen HN; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhang WH; Division of Gastrointestinal Surgery, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Shu Y; School of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju, Republic of Korea.
  • Kong X; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Ren Z; School of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju, Republic of Korea.
  • Li PH; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Liu Y; Colorectal Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Tang H; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Sun R; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Li C; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Bai B; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Jia W; Division of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Liu Y; Laboratory of thyroid and parathyroid disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhang W; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Yang L; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Peng Y; Division of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Dai L; Laboratory of thyroid and parathyroid disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Hu H; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Jiang Y; Division of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Hu Y; Laboratory of thyroid and parathyroid disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Zhu J; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Jiang H; Health Promotion Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Li Z; Division of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Caulin C; Laboratory of thyroid and parathyroid disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Park J; Department of Head and Neck Surgery, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
  • Xu H; Department of Head and Neck Surgery, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Nat Commun ; 13(1): 6619, 2022 11 04.
Article em En | MEDLINE | ID: mdl-36333338
ABSTRACT
Cancer-associated fibroblasts (CAFs) are the predominant components of the tumor microenvironment (TME) and influence cancer hallmarks, but without systematic investigation on their ubiquitous characteristics across different cancer types. Here, we perform pan-cancer analysis on 226 samples across 10 solid cancer types to profile the TME at single-cell resolution, illustrating the commonalities/plasticity of heterogenous CAFs. Activation trajectory of the major CAF types is divided into three states, exhibiting distinct interactions with other cell components, and relating to prognosis of immunotherapy. Moreover, minor CAF components represent the alternative origin from other TME components (e.g., endothelia and macrophages). Particularly, the ubiquitous presentation of endothelial-to-mesenchymal transition CAF, which may interact with proximal SPP1+ tumor-associated macrophages, is implicated in endothelial-to-mesenchymal transition and survival stratifications. Our study comprehensively profiles the shared characteristics and dynamics of CAFs, and highlight their heterogeneity and plasticity across different cancer types. Browser of integrated pan-cancer single-cell information is available at https//gist-fgl.github.io/sc-caf-atlas/ .
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibroblastos Associados a Câncer / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibroblastos Associados a Câncer / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article